PharmaCyte Biotech Inc

Research PharmaCyte Biotech Inc (PMCB) on Bullrun: market cap USD 7.85M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPMCB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.85M
• Financial periodFY2025
• Net incomeUSD 30.66M

Valuation Snapshot

latest market cap is USD 7.85M.

About PharmaCyte Biotech Inc

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors.

Frequently asked questions

What is PharmaCyte Biotech Inc's market cap?

PharmaCyte Biotech Inc's market capitalization is USD 7.85M.

What does PharmaCyte Biotech Inc do?

PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States.